4/14/2026China Unveils New Drug Pricing Reform to Balance Innovation, Affordabi...

4/14/2026China Moves to Strengthen Community Healthcare and Expand Rehabilitati...

4/14/2026China-Indonesia Deepens HPV Vaccine Collaboration to Expand Access and...

4/13/2026China CDE Releases Patient-Centered Clinical Development Guideline for...

4/13/2026China CDE Opens Public Consultation on Draft ARC CMC Guideline

4/13/2026Haisco Signs Global ex-China Pain Deal With AbbVie for Selective Nav1....

4/13/2026BioNTech and DualityBio Report Positive Registrational Phase 2 Results...

4/13/2026Innovent Presents Preclinical Oral Data for Tri-Specific Autoimmune T-...

4/13/2026GenScript Partners With Mimulus to Industrialize DNA Data Storage for ...

4/13/2026Oculgen Launches Global Phase II/III Trial of OCUL101 in Wet AMD

4/13/2026CanSino Wins China Approval for Three-Component DTcP Combination Vacci...

4/13/2026AstraZeneca's Imjudo Wins China Approval, Likely for First-Line EGFR/A...

4/13/2026BeOne Secures China Conditional Approval for Imdylltra in Third-Line E...

4/13/2026Vivatides Emerges With $10M Seed Round to Advance Extrahepatic RNAi Pl...

4/10/2026NHSA Launches First Public Disclosure for Reference Drug Pre-Communica...

4/10/2026CDE Seeks Comments on New Technical Guideline for Staged Manufacturing...

4/10/2026China Unveils Sweeping Measures to Accelerate Tiered Healthcare System...

4/10/2026Xuanzhu Expands Global Oncology Reach With Boston Oncology Licensing D...

4/10/2026DualityBio Wins China BLA Acceptance for HER2 Breast Cancer ADC, Movin...

4/10/2026IMPACT Thera Secures $5M Milestone as PARP1-Selective IMP1734 Advances...

4/10/2026Oricell Raises Over $110M Pre-IPO to Advance Global Solid Tumor CAR-T ...

4/9/2026CDE Releases New Clinical Evaluation Guideline for IND Applications to...

4/9/2026CDE Issues New Clinical Evaluation Guideline for Drug Marketing Applic...

4/9/2026Syneron Emerges as a Macrocycle Powerhouse as Funding and AZ Deal Fuel...

4/9/2026Luye Advances Next-Gen Schizophrenia Candidate LY03020 Into Phase II i...

4/9/2026Over Half of China-Listed Drugmakers Grow 2025 Profit as Innovation an...

4/9/2026Gan & Lee Out-Licenses Bi-Weekly GLP-1 Candidate Bofanglutide to JW Ph...

4/9/2026GSK Wins China Approval for Exdensur in Chronic Rhinosinusitis With Na...

4/9/2026NMPA Clears BioGenesis's Recombinant Human Hyaluronidase

4/9/2026Everest Medicines to Acquire Hasten's Asia-Pacific Platform in $250M ...

Page:1/61 Total number of articles:1830: [First][<<] [1] [2] [3] [4] [5] [>>] [End]